Provided by Tiger Fintech (Singapore) Pte. Ltd.

SCYNEXIS Inc

1.02
-0.0450-4.23%
Post-market: 1.020.00000.00%17:00 EDT
Volume:103.57K
Turnover:108.04K
Market Cap:39.76M
PE:-2.32
High:1.10
Open:1.05
Low:1.00
Close:1.07
Loading ...

SCYNEXIS to Present Preclinical Data on Second Generation IV/Oral Fungerp SCY-247 at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)

GlobeNewswire
·
08 Apr

SCYNEXIS Full Year 2024 Earnings: Misses Expectations

Simply Wall St.
·
14 Mar

Scynexis Initiates Dosing in Phase 1 Trial of Scy-247, a Second-Generation Fungerp Candidate for Invasive Fungal Infections

THOMSON REUTERS
·
18 Dec 2024

SCYNEXIS Initiates Dosing in Phase 1 Trial of SCY-247, a Second-Generation Fungerp Candidate for Invasive Fungal Infections

GlobeNewswire
·
18 Dec 2024

Maxim Group Keeps Their Buy Rating on SCYNEXIS (SCYX)

TIPRANKS
·
05 Dec 2024

SCYNEXIS (NASDAQ:SCYX) adds US$6.5m to market cap in the past 7 days, though investors from five years ago are still down 86%

Simply Wall St.
·
30 Nov 2024

Analysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK) and SCYNEXIS (SCYX)

TIPRANKS
·
12 Nov 2024

SCYNEXIS Inc expected to post earnings of 3 cents a share - Earnings Preview

Reuters
·
08 Nov 2024

SCYNEXIS Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
08 Nov 2024

Scynexis: Q3 Earnings Snapshot

Associated Press Finance
·
07 Nov 2024

SCYNEXIS Q3 EPS $(0.06) Beats $(0.07) Estimate

Benzinga
·
07 Nov 2024

BRIEF-Scynexis Q3 EPS USD -0.06

Reuters
·
07 Nov 2024

Scynexis Reports Third Quarter 2024 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
07 Nov 2024

Scynexis Q3 Product Revenue USD 660 Thousand

THOMSON REUTERS
·
07 Nov 2024

Scynexis Q3 Pretax Profit USD -3.203 Million

THOMSON REUTERS
·
07 Nov 2024

SCYNEXIS Reports Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire
·
07 Nov 2024

BRIEF-Scynexis enters into controlled equity offering sales agreement

Reuters
·
07 Nov 2024

Scynexis- Entered Into Controlled Equity Offering Sales Agreement, May Offer & Sell Shares of Common Stock for $50 Mln From Time to Time

THOMSON REUTERS
·
07 Nov 2024

Investors in SCYNEXIS (NASDAQ:SCYX) have unfortunately lost 89% over the last five years

Simply Wall St.
·
30 Oct 2024